Taxpayers Protection Alliance

https://www.protectingtaxpayers.org/
[email protected]
(202) 930-1716
1401 K Street NW, Washington, DC 20005
Issue and Policy Advocacy
Non-Profit Orgs
back to directoryBack to Directory

Related Posts:

Former FDA official responds – in part – to Taxpayers Protection Alliance’s suggested reforms
Former FDA official responds – in part – to Taxpayers Protection Alliance’s suggested reforms

October 18, 2019

Dr. David Gortler, former Food and Drug Administration (FDA) official, drug safety and FDA regulatory affairs expert and pharmacology professor, responds to the Taxpayers Protection Alliances’ (TPA) list of recommendations to improve business strategies released Oct. 3.

Read more →
Taxpayers Protection Alliance recommends FDA reforms
Taxpayers Protection Alliance recommends FDA reforms

October 10, 2019

The U.S. Food and Drug Administration (FDA) holds primary responsibility for approving and regulating various human and animal prescription drugs, medical and tobacco products and the nation’s food supply.

Read more →

Trending

BAYER: U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint Data to NUBEQA® (darolutamide) Prescribing Information
LOCATE BIO: CognitOss Granted FDA Breakthrough Device Designation
NORTHSTAR MEDICAL RADIOISOTOPES: Announces FDA Approval for Enhanced U.S. Mo-99 Radioisotope Production Capacity
KING & SPALDING: FDA and Life Sciences Team Adds Partner in Washington
FUNCTIONAL NEUROMODULATION: Announces Breakthrough Device Designation from the U.S. FDA for Deep Brain Stimulation for Alzheimer’s Disease
ULTROMICS: Receives Fda Clearance for a First-of-kind Solution in Echocardiography to Help Clinicians Diagnose Disease

The Weekly Newsletter

Sign-up for the Weekly Newsletter from FDA Reporter.